Logo

QuantumDx

In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More

News items for the week of Dec. 12, 2022.

Menarini to Distribute QuantuMDx Point-of-Care MDx System, Tests in UK and France

The deal includes QuantuMDx's recently launched assays for SARS-CoV-2, influenza, and respiratory syncytial virus.

QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel

The panel, which tests for flu, respiratory syncytial virus, and SARS-CoV-2, expands the company's menu for the molecular Q-POC platform.

In Brief This Week: Labcorp, QuantuMDx, PerkinElmer, Bruker, Pathomics Health, More

News items for the week of March 7, 2022.

In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More

News items for the week of Feb. 21, 2022.

Nov 8, 2021

QuantuMDx Gets £15M Investment From Vita Spring IVD Fund for Portable PCR Platform Development

Aug 4, 2021

QuantuMDx Developing Point-of-Care Multiplex System, Syndromic Panels for European Launch
Premium

Jul 9, 2021

QuantumDx Gets CE Mark for Rapid Point-of-Care PCR System

May 11, 2021

CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC

Mar 24, 2021

QuantuMDx Raises $15.1M to Support Scale Up of Point-of-Care Molecular Diagnostic System

Jun 8, 2020

QuantuMDx Receives CE-IVD Marking for SARS-CoV-2 Test

Feb 12, 2020

Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus
Premium

Jan 27, 2020

QuantuMDx Raises $14M to Support Development of POC Genotyping Assay

Dec 10, 2019

Ontera, QuantuMDx Partner on Sepsis Test Development

Nov 7, 2019

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

Feb 21, 2019

With Studies Underway in South America and Asia, QuantuMDx Readies POC Platform for Launch
Premium

Dec 21, 2018

In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More

Jan 24, 2018

QuantuMDx Raises $12M

Feb 2, 2017

QuantuMDx, Global Good Partner on POC Cervical Cancer Screening in Low-Resource Settings
Premium

Nov 28, 2016

QuantuMDx Wins Gates Foundation Funds for Point-of-Care TB MDx
Premium

Jun 9, 2015

QuantuMDx, Scienion Partner to Commercialize Nanowire Biosensor

Oct 28, 2014

IP Roundup: CalTech, QuantumDx, Fluidigm Win US Patents
Premium

Oct 28, 2014

FIND Collaborates with Multiple Firms on MDx Tests for TB

Sep 16, 2014

With Handheld Test Device Prototype Ready, QuantuMDx Seeks Financing to Support Commercial Launch
Premium

Jul 1, 2014

People in the News: John Burn, Andrzej Jakubowiak, Shaji Kumar, Sagnar Lonial, Gareth Morgan, Antonio Palumbo, and Others
Premium

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.